← Back to India
IN

Cipla Limited

CIPLA · NSE · Pharmaceuticals · Generics

Cipla Limited is number 48 by indicative market capitalization among the 50 listed companies tracked here for India (data year 2024).

About the company

Cipla is one of India's major generic pharmaceutical companies, with a strong domestic branded generics business and significant exports to regulated markets including the United States, South Africa, and Europe. The company is known for its role in making affordable HIV/AIDS medicines globally and has a broad respiratory, cardiovascular, and anti-infective product portfolio. Cipla has been expanding its US complex generics and specialty pipeline.

ExchangeNSE
TickerCIPLA
SectorPharmaceuticals · Generics
Indicative market cap USD$13.00B
WebsiteVisit website

Live quote

Loading live price…

Where to buy

On its home market (NSE), it is accessible through global brokers that offer that exchange:

Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.

Other ways to get exposure

Single-country ETFs covering India (a fund may or may not hold this company; check its holdings):

Other companies in India

Reliance Industries Limited$221.00BHDFC Bank Limited$178.00BBharti Airtel Limited$134.00BTata Consultancy Services Limited$125.00BICICI Bank Limited$119.00BState Bank of India$100.00BInfosys Limited$80.00BBajaj Finance Limited$73.00B

Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker. Report an error

Theme